pubmed-article:1500475 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:1500475 | lifeskim:mentions | umls-concept:C0026727 | lld:lifeskim |
pubmed-article:1500475 | lifeskim:mentions | umls-concept:C0003241 | lld:lifeskim |
pubmed-article:1500475 | lifeskim:mentions | umls-concept:C1704675 | lld:lifeskim |
pubmed-article:1500475 | lifeskim:mentions | umls-concept:C0237881 | lld:lifeskim |
pubmed-article:1500475 | lifeskim:mentions | umls-concept:C0750502 | lld:lifeskim |
pubmed-article:1500475 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:1500475 | pubmed:dateCreated | 1992-9-17 | lld:pubmed |
pubmed-article:1500475 | pubmed:abstractText | An overview is presented of the effects of antisperm antibodies on the sperm-cervical mucus interaction. Antisperm IgA on spermatozoa or in cervical mucus can severely inhibit sperm penetration of cervical mucus and migration through it. Disturbance of the sperm-cervical mucus interaction is the only firmly established effect of these antisperm antibodies and leads to reduced fertility, as shown by a poor or negative result of the post-coital test. The presence of antisperm IgA in the male or female partner can be investigated more specifically with the sperm-cervical mucus contact test and can be confirmed by the sperm agglutination test on bromelinliquefied cervical mucus, by the mixed antiglobulin reaction test or by the immunobead test for IgA. | lld:pubmed |
pubmed-article:1500475 | pubmed:language | eng | lld:pubmed |
pubmed-article:1500475 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1500475 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:1500475 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1500475 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1500475 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:1500475 | pubmed:month | Jul | lld:pubmed |
pubmed-article:1500475 | pubmed:issn | 0268-1161 | lld:pubmed |
pubmed-article:1500475 | pubmed:author | pubmed-author:KremerJJ | lld:pubmed |
pubmed-article:1500475 | pubmed:author | pubmed-author:JagerSS | lld:pubmed |
pubmed-article:1500475 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:1500475 | pubmed:volume | 7 | lld:pubmed |
pubmed-article:1500475 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:1500475 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:1500475 | pubmed:pagination | 781-4 | lld:pubmed |
pubmed-article:1500475 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:1500475 | pubmed:meshHeading | pubmed-meshheading:1500475-... | lld:pubmed |
pubmed-article:1500475 | pubmed:meshHeading | pubmed-meshheading:1500475-... | lld:pubmed |
pubmed-article:1500475 | pubmed:meshHeading | pubmed-meshheading:1500475-... | lld:pubmed |
pubmed-article:1500475 | pubmed:meshHeading | pubmed-meshheading:1500475-... | lld:pubmed |
pubmed-article:1500475 | pubmed:meshHeading | pubmed-meshheading:1500475-... | lld:pubmed |
pubmed-article:1500475 | pubmed:meshHeading | pubmed-meshheading:1500475-... | lld:pubmed |
pubmed-article:1500475 | pubmed:meshHeading | pubmed-meshheading:1500475-... | lld:pubmed |
pubmed-article:1500475 | pubmed:meshHeading | pubmed-meshheading:1500475-... | lld:pubmed |
pubmed-article:1500475 | pubmed:meshHeading | pubmed-meshheading:1500475-... | lld:pubmed |
pubmed-article:1500475 | pubmed:meshHeading | pubmed-meshheading:1500475-... | lld:pubmed |
pubmed-article:1500475 | pubmed:year | 1992 | lld:pubmed |
pubmed-article:1500475 | pubmed:articleTitle | The significance of antisperm antibodies for sperm-cervical mucus interaction. | lld:pubmed |
pubmed-article:1500475 | pubmed:affiliation | Department of Obstetrics and Gynaecology, University Hospital, Groningen, The Netherlands. | lld:pubmed |
pubmed-article:1500475 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1500475 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1500475 | lld:pubmed |